Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia

Código QR

Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia

Guardado en:

Detalles Bibliográficos
Autores principales:	Yi Wang, Taha Merghoub, Peihong Dai, Weiyi Wang, Ning Yang, Liang Deng, Shuaitong Liu, Rachel A Giese
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/13292f25f74f4efc8b5effdaa20268a5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway.
por: Peihong Dai, et al.
Publicado: (2014)

IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
por: Xiaoyan Zhang, et al.
Publicado: (2021)

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
por: Zuqiang Liu, et al.
Publicado: (2017)

Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs
por: Jérémy Béguin, et al.
Publicado: (2021)

Correction: IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
Publicado: (2021)

Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter.
por: Dana Haddad, et al.
Publicado: (2012)

Route-coupled pathogenicity and immunogenicity of vaccinia virus variant inoculated mice
por: S. N. Shchelkunov, et al.
Publicado: (2021)

Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library
por: Ulrike S. Diesterbeck, et al.
Publicado: (2021)

Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.
por: Don B Gammon, et al.
Publicado: (2010)

Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination.
por: Sjoerd H E van den Worm, et al.
Publicado: (2012)

A36-dependent actin filament nucleation promotes release of vaccinia virus.
por: Jacquelyn Horsington, et al.
Publicado: (2013)

Structure and function of A41, a vaccinia virus chemokine binding protein.
por: Mohammad W Bahar, et al.
Publicado: (2008)

The vaccinia virus DNA polymerase structure provides insights into the mode of processivity factor binding
por: Nicolas Tarbouriech, et al.
Publicado: (2017)

EVALUATION OF IMMUNOGENICITY AND PTOTECTIVENESS OF THE VACCINIA VIRUS LIVP-GFP IN THREE LABORATORY ANIMAL SPECIES
por: S. Shchelkunov, et al.
Publicado: (2019)

Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine.
por: Hong Chen, et al.
Publicado: (2012)

Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
por: Zuqiang Liu, et al.
Publicado: (2018)

Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
por: Akiko Eto, et al.
Publicado: (2021)

Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain.
por: Qicheng Zhang, et al.
Publicado: (2013)

Single dose of a replication-defective vaccinia virus expressing Zika virus-like particles is protective in mice
por: Brittany Jasperse, et al.
Publicado: (2021)

A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer
por: Jahangir Ahmed, et al.
Publicado: (2021)

A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme
por: Inga R. Grin, et al.
Publicado: (2021)

The Efficacy of Disinfection on Modified Vaccinia Ankara and African Swine Fever Virus in Various Forest Soil Types
por: Franziska Tanneberger, et al.
Publicado: (2021)

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo
por: Arwen F. Altenburg, et al.
Publicado: (2017)

Neutrophil subtypes shape HIV-specific CD8 T-cell responses after vaccinia virus infection
por: Mauro Di Pilato, et al.
Publicado: (2021)

Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins
por: Linda S. Wyatt, et al.
Publicado: (2017)

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.
por: Rakesh Kulkarni, et al.
Publicado: (2021)

Impaired cellular responses to cytosolic DNA or infection with Listeria monocytogenes and vaccinia virus in the absence of the murine LGP2 protein.
por: Darja Pollpeter, et al.
Publicado: (2011)

Correction: A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer
Publicado: (2021)

Granzyme B inhibits vaccinia virus production through proteolytic cleavage of eukaryotic initiation factor 4 gamma 3.
por: Marcelo Marcet-Palacios, et al.
Publicado: (2011)

A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
por: Natalie A. Prow, et al.
Publicado: (2018)

Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations
por: Rafael M. Couñago, et al.
Publicado: (2017)

Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.
por: Julie Delaloye, et al.
Publicado: (2009)

Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence.
por: Carlos Maluquer de Motes, et al.
Publicado: (2011)

Comparing adjuvanted H28 and modified vaccinia virus ankara expressingH28 in a mouse and a non-human primate tuberculosis model.
por: Rolf Billeskov, et al.
Publicado: (2013)

An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma
por: Bo Xu, et al.
Publicado: (2021)

Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm.
por: Xianfeng Zhang, et al.
Publicado: (2012)

Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer
por: Aditi Gupta, et al.
Publicado: (2021)

A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses.
por: Juan García-Arriaza, et al.
Publicado: (2011)

A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
por: Krishna Das, et al.
Publicado: (2021)

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
por: Naiara Martínez-Vélez, et al.
Publicado: (2019)